APPENDICES: a Systematic Review of Photodynamic Therapy in the Treatment of Pre-Cancerous Skin Conditions, Barrett's Oesophagu
Total Page:16
File Type:pdf, Size:1020Kb
Health Technology Assessment 2010; Vol. 14: No.371 Health Technology Assessment 2010; Vol. 14: No. 37 Appendix 5 Pre-cancerous skin scoping Appendix 6 Appendices Go to main text Skin cancer scoping Appendix 7 Barrett’s oesophagus scoping Appendix 8 Oesophageal cancer scoping A systematic review of photodynamic Appendix 9 therapy in the treatment of pre- Lung cancer scoping cancerous skin conditions, Barrett’s Appendix 10 oesophagus and cancers of the biliary Biliary tract cancer scoping Appendix 11 tract, brain, head and neck, lung, Brain cancer scoping oesophagus and skin Appendix 12 Head and neck cancer scoping D Fayter, M Corbett, M Heirs, D Fox Appendix 13 and A Eastwood Actinic keratosis data extraction Appendix 14 Bowen’s disease data extraction Appendix 15 Basal cell carcinoma data extraction Appendix 16 Barrett’s oesophagus data extraction Appendix 17 Oesophageal cancer data extraction Appendix 18 Lung cancer data extraction Appendix 19 Biliary tract cancer data extraction Appendix 20 Brain cancer data extraction Appendix 21 July 2010 Head and neck cancer data extraction 10.3310/hta14370 Health Technology Assessment NIHR HTA programme www.hta.ac.uk HTA How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below). Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order: – fax (with credit card details) – post (with credit card details or cheque) – phone during office hours credit( card only). Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows: Synergie UK (HTA Department) Email: [email protected] Digital House, The Loddon Centre Tel: 0845 812 4000 – ask for ‘HTA Payment Services’ Wade Road (out-of-hours answer-phone service) Basingstoke Hants RG24 8QW Fax: 0845 812 4001 – put ‘HTA Order’ on the fax header Payment methods Paying by cheque If you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address. Paying by credit card You can order using your credit card by phone, fax or post. Subscriptions NHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40–50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume. How do I get a copy of HTA on DVD? Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide. The website also provides information about the HTA programme and lists the membership of the various committees. DOI: 10.3310/hta14370 Health Technology Assessment 2010; Vol. 14: No. 37 Appendix 5 Pre-cancerous skin scoping ne hundred and thirty-three publications, with 9. Baron E, Domingo DS, Hsia A, Colussi V, Oleinick N, Foster T, et al. Silicon phthalocyanine study designs that did not meet the inclusion O photodynamic therapy for treatment of cutaneous criteria for the review, reported on patients with neoplasms. J Invest Dermatol 2008;128:395. pre-cancerous skin conditions being treated with PDT. The references are listed below, in 10. Berking C, Herzinger T, Flaig MJ, Brenner M, alphabetical order; they have not been categorised Borelli C, Degitz K. The efficacy of photodynamic and may still contain a number of duplicate therapy in actinic cheilitis of the lower lip: a publications. prospective study of 15 patients. Dermatol Surg 2007;33:825–30. References 11. Berroeta L, Lewis-Jones MS, Evans AT, Ibbotson 1. Alexiades-Armenakas MR, Bernstein LJ, Chen SH. Woringer-Kolopp (localized pagetoid J, Jacobson L, Geronemus R. Laser-assisted reticulosis) treated with topical photodynamic photodynamic therapy of actinic keratoses: long- therapy (PDT). Clin Exp Dermatol 2005;30:446–7. term follow-up. Lasers Surg Med 2003;15(Suppl.):45. 12. Breuninger H, Bonnekoh B, Gollnick 2. Alexiades-Armenakas MR, Geronemus RG. H. Photodynamic therapy with Laser-mediated photodynamic therapy of actinic methylaminooxopentanoate (MetvixR) and a broad keratoses. Arch Dermatol 2003;139:1313–20. band light source (PhotoDyn 501): Experiences in complicated patients with actinic keratoses 3. Ammann R, Hunziker T. Photodynamic therapy for and basal cell carcinomas [Multiple letters]. mycosis fungoides after topical photosensitization JDDG (Journal of the German Society of Dermatology) with 5-aminolevulinic acid. J Am Acad Dermatol 2005;3:397. 1995;33:541. 13. Britton JER, Goulden V, Stables G, Stringer M, 4. Antoniou C, Katsambas A, Rigopoulos D, Palaskas Sheehan-Dare R. Investigation of the use of the E, Tsikrikas GN. Aminolevulinic acid: topical pulsed dye laser in the treatment of Bowen’s disease photodynamic therapy in skin cancers and solar using 5-aminolaevulinic acid phototherapy. Br J keratoses. Skin Cancer 1996;11:81–4. Dermatol 2005;153:780–4. 5. Attili S, Cochrane A, McNeill A, Camacho-Lopez 14. Brookes PT, Jhawar S, Hinton CP, Murdoch S, M, Moseley H, Ibbotson S, et al. An open pilot Usman T. Bowen’s disease of the nipple: a new study of ambulatory photodynamic therapy using a method of treatment. Breast (Edinburgh, Scotland) wearable, low-irradiance, organic LED light source 2005;14:65–7. in the treatment of nonmelanoma skin cancer. Br J Dermatol 2008;159:130–1. 15. Buchanan RB, Carruth JA, McKenzie AL, Williams SR. Photodynamic therapy in the treatment of 6. Bakos RM, Bakos L, Ferlin E, Cestari T, Orlandini T, malignant tumours of the skin and head and neck. Rezende R, et al. [Photodynamic therapy with delta- Eur J Surg Oncol 1989;15:400–6. aminolevulinic acid for superficial keratinocytic neoplasms.] An Bras Dermatol 2003;78:197–207. 16. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy 7. Baptista J, Martinez C, Leite L, Cochito M. Our with topical 5-aminolaevulinic acid for superficial PDT experience in the treatment of non-melanoma primary and secondary skin cancer. Br J Cancer skin cancer over the last 7 years. J Eur Acad Dermatol 1994;69:605–8. Venereol 2006;20:693–7. 17. Calzavara-Pinton PG. Repetitive photodynamic 8. Baptista J, Paris F, Serrao V, Cochito M. Topical therapy with topical delta-aminolaevulinic acid as photodynamic therapy and imiquimod cream in the an appropriate approach to the routine treatment of treatment of actinic keratoses: a case report. Skin superficial non-melanoma skin tumours. J Photochem Cancer 2006;21:49–53. Photobiol B 1995;29:53–7. 131 © 2010 Queen’s Printer and Controller of HMSO. All rights reserved. Appendix 5 18. Calzavara-Pinton PG, Venturini M, Sala R, disease and basal cell carcinoma. J Eur Acad Dermatol Capezzera R, Parrinello G, Specchia C, et al. Venereol 2001;15:550–4. Methylaminolaevulinate-based photodynamic therapy of Bowen’s disease and squamous cell 29. Dragieva G, Hafner J, Dummer R, Schmid- carcinoma. Br J Dermatol 2008;159:137–44. Grendelmeier P, Roos M, Prinz BM, et al. Topical photodynamic therapy in the treatment of actinic 19. Calzavara-Pinton PG, Zane C, Facchetti F, Carlino keratoses and Bowen’s disease in transplant A, Blanzuoli L, Marocolo D, et al. [Photodynamic recipients. Transplantation 2004;77:115–21. therapy of non-melanoma skin tumours with topical delta-aminolevulinic acid.] G Ital Dermatol Venereol 30. Erboz S, Ceylan C, Ozdemir F, Kazandi A, Ozol A. 1997;132:15–21. [Photodynamic treatment in solar keratosis.] Deri Hast Frengi Ars 1999;33:75–8. 20. Carruth JAS, Barrett JM, Barnes DWH, Buchanan RB, Sansom JM. A trial of photodynamic therapy 31. Fernandez-Guarino M, Harto A, Perez-Garcia for the treatment of tumors of the skin and head B, Martin-Gonzalez M, Urrutia S, Jaen P. and neck, and the results of an experimental- Photodynamic therapy in disseminated superficial study to determine the Interrelationships between actinic porokeratosis. J Eur Acad Dermatol Venereol the tissue effects of ionizing-radiation and 2009;23:176–7. photodynamic therapy. SPIE Proceedings Series 1993;1616:14–19. 32. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta- 21. Cavicchini S, Moretti D, Tanzi C, Tourlaki A. MAL- aminolaevulinic acid and desferrioxamine. Br J PDT in “difficult to treat’’ Bowen’s disease. J Invest Dermatol 1995;133:282–8. Dermatol 2006;126:S36. 33. Fink-Puches R, Hofer A, Smolle J, Kerl H, Wolf P. 22. Ceylan C, Erboz S, Ozdemir F, Alper S. Topical Primary clinical response and long-term follow-up photodynamic therapy for intraepidermal of solar keratoses treated with topically applied epithelioma. J Eur Acad Dermatol Venereol 5-aminolevulinic acid and irradiation by different 2002;16:292–4. wave bands of light. J Photochem Photobiol B 1997;41:145–51. 23. Ceylan C, Erboz S, Ozdemir F, Kazandi A. [The effectiveness of topical photodynamic therapy in 34. Fowler JF, Jr, Zax RH. Aminolevulinic acid actinic.] Deri Hast Frengi Ars 2001;35:213–18. hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment. 24. Cochito M, Campos Lopes JM, Leite L. Topical Cutis 2002;69:2–7. photodynamic therapy in a case of Bowen’s disease of the face.